Our previous study demonstrated that LukS-PV can induce differentiation and apoptosis in leukemia cells by targeting C5aR1, displaying antileukemia activity in vitro and in vivo, without noticeable side effects in mice (18, 19, 20, 21). This evidence concerns the gene C5AR1 and leukemia.